Descriptive epidemiology of thyroid cancer in France: Incidence, mortality and survival;Épidémiologie descriptive du cancer thyroïdien en France: Incidence, mortalité et survie

Annales d'Endocrinologie

Volumn 71, Issue 2, 2010, Pages 95-101

  Colonna, M ^a,b   Bossard, N ^c,d   Guizard, A V ^b,e   Remontet, L ^c,d   Grosclaude, P ^b,f  

^a Registre du cancer de l'Isère ^*  (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e CENTRE FRANÇOIS BACLESSE   (France)

^f Registre des cancers du Tarn   (France)

Author keywords

Histological type; Incidence; Mortality; Survival; Thyroid cancer

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; DESCRIPTIVE RESEARCH; FEMALE; FRANCE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SEX RATIO; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 77952956706     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2009.11.006     Document Type: Article

References (21)

1. Belot A., Grosclaude P., Bossard N., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publ 2008, 56:159-175.
2. Hospices Civils de Lyon - Institut de veille sanitaire - Institut National du Cancer - Francim - Institut National de la Santé et de la Recherche médicale. Projections de l'incidence et de la mortalité par cancer en France pour l'année 2008. Rapport technique, mars2009. (http://www.invs.sante.fr/surveillance/cancers).
3. Remontet L., Bossard N., Belot A., Estève J. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007, 26:2214-2228. the French network of cancer registries (FRANCIM).
4. Bossard N., Velten M., Remontet L., et al. Survival of cancer patients in France: A population-based study from the Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007, 43:149-160.
5. Réseau FRANCIM. Survie des patients atteints de cancer en France. Étude des registres de cancers du réseau FRANCIM. Paris: Springer-Verlag; 2007.
6. Colonna M., Grosclaude P., Remontet L., et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 2002, 38:1762-1768.
7. Chérié-Challine L. Surveillance sanitaire en lien avec l'accident de Tchernobyl en France - bilan actualisé sur les cancers thyroïdiens et études épidémiologiques en cours en 2006 2006, Les membres du comité de rédaction, Institut de veille sanitaire, Saint-Maurice, www.invs.sante.fr.
8. Verkooijen H.M., Fioretta G., Pache J.C., et al. Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 2003, 14:13-17.
9. Leenhardt L., Bernier M.O., Boin-Pineau M.H., et al. Advances in diagnosis practices affect thyroid cancer incidence in France. Eur J Endocrinol 2004, 150:133-139.
10. Colonna M., Guizard A.V., Schartz C., et al. Time trend analysis of papillary and follicular cancers as a function of tumour size: A study of data from six cancer registries in France (1983-2000). Eur J Cancer 2007, 43:891-900.
11. Hedinger C., Williams E.D., Sobin L.H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989, 63:908-911.
12. Cardis E., Krewski D., Boniol M., et al. Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer 2006, 119:1224-1235.
13. Leux C., Guénel P. Facteurs de risque des cancers et nodules thyroïdiens: effet des polluants de l'environnement et risques professionnels. Med Clin Endocrinol Diabete 2009, 1-7.
14. Curado P, Edwards B, Shin H, Storm H, Ferlay J, Heanue M, Boyle P. Cancer incidence in five continents, Vol. IX. IARC Scientific Publications 160, Lyon, International Agency for Research on Cancer, 2007.
15. Akslen L., Haldorsen T., Thoresen S.O., Glattre E. Survival and causes of death in thyroid cancer: A population-based Study of 2479 Cases from Norway. Cancer Res 1991, 51:1234-1241.
16. Cunningham M.P., Duda R.B., Recant W., Cmiel J.S., Sylvester J.A., Fremgen A. Survival discriminants for differentiated thyroid cancer. Am J Surg 1990, 160:344-347.
17. Colonna M., Grande E., Jonasson J.G. Cancer Variation in relative survival of thyroid cancers in Europe: Results from the analysis on 21 countries over 4 the period 1983-1994 (EUROCARE-3 study). Eur J Cancer 2006, 42:2598-2608. the EUROCARE Working Group.
18. Guilliland F.D., Hunt W.C., Morris D.M., Key X.R. Prognostic factors for thyroid carcinoma. Cancer 1997, 19:564-573.
19. Esik O., Tusnády G., Trón L., et al. Markov model-based estimation of individual survival probability for medullary thyroid cancer patients. Pathol Oncol Res 2002, 8:93-104.
20. Sassolas G., Hafdi-Nejjari1 Z., Remontet L., et al. Thyroid cancer: is the incidence rise abating?. Eur J Endocrinol 2008, 159:1-10.
21. Ries L, Melbert D, Krapcho M, Stinchcomb DG et al. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, 2009. (). http://seer.cancer.gov/csr/1975_2005/.